When sponsors of trials adopt IQVIA One Home for Sites, they reduce the burden on their clinical research sites and on their own organizations.

Launching a study is complex, and the time between protocol approval and the first patient visit has increased dramatically. How can companies reverse this trend and accelerate study start-ups?

Join the movement to increase clinical research site capacity. IQVIA One Home for Sites serves as a neutral aggregator, connector, and communicator of the key systems and tasks sites need to perform.

As protocols and studies become more complex, using technology to offer sites in-depth expertise and guidance is more important than ever to launch studies on time.

Dive deep into the capabilities of IQVIA's eCOA with our expert Edward Bartels. He will focus on how to effortlessly create a diary, schedule site/participant assessments, and intuitively manage translations and compliance.

In this comprehensive guide, IQVIA's eCOA library and licensing specialists, Kayla Doyle and Piero Bindi, explore five essential steps for obtaining licenses for the assessments required in your clinical trial.

Each device, with its unique technology and study parameters, presents a distinctive challenge that demands precision at every turn. Learn how we can help to revolutionize your medical device trial journey.

Delve into the art of tailoring the eConsent experience to match the specific needs of your study and patients, such as how to craft patient-centric eConsent documents, select appropriate delivery models, and more.